Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors

Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors

Immunotherapies based on immune checkpoint blockade have shown remarkable clinical outcomes and durable responses in patients with many tumor types. Nevertheless, these therapies lack efficacy in most cancer patients, even causing severe adverse events in a small subset of patients, such as inflamma...

Full description

Bibliographic Details
Main Authors: Ester Blanco, Luisa Chocarro, Leticia Fernández-Rubio, Ana Bocanegra, Hugo Arasanz, Miriam Echaide, Maider Garnica, Sergio Piñeiro-Hermida, Grazyna Kochan, David Escors
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
monoclonal antibodies (mAbs)
intratumoral therapy
viral therapy
non-viral therapy
Online Access:https://www.mdpi.com/1422-0067/24/3/2676

Internet

https://www.mdpi.com/1422-0067/24/3/2676

Similar Items